CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) (USD $)	Jun. 30, 2012		Dec. 31, 2011
Current assets:
Cash and cash equivalents	$ 2,654,694		$ 4,112,326
Accounts receivable, net	3,946,333		1,891,919
Inventory, net	961,939		712,602
Prepaid expenses and other current assets	292,223		164,664
Total current assets	7,855,189		6,881,511
Property and equipment, net of accumulated depreciation of $2,045,964 and $1,814,473, respectively	948,720		869,411
Goodwill	4,040,443		4,040,443
Intangible assets, net of accumulated amortization of $4,136,469 and $3,468,515, respectively	14,422,531	[1]	15,090,485	[1]
Deposits and other long term assets	204,803		214,342
Total assets	27,471,686		27,096,192
Current liabilities:
Accounts payable and accrued expenses	1,902,349		2,300,638
Other current liabilities	69,981		6,620
Convertible line of credit with related party, net of unamortized discount of $398,899 and $46,746, respectively, plus accrued interest of $75,137 and $42,726, respectively	976,238		1,295,980
Convertible debt related to acquisition, net of unamortized discount of $3,821 and $170,509, respectively, plus accrued interest of $69,808 and $49,315, respectively	1,065,987		1,128,806
Current portion of earn-out liability payable In MiMedx common stock	4,225,280		3,185,223
Total current liabilities	8,239,835		7,917,267
Earn-out liability payable in MiMedx common stock, net of current portion	0		4,225,280
Convertible Senior Secured Promissory Notes, net of unamortized discount of $1,818,446 and $2,263,145, respectively, plus accrued interest of $61,933 and $7,732, respectively	3,243,487		2,744,587
Other liabilities	320,055		312,493
Total liabilities	11,803,377		15,199,627
Commitments and contingencies (Note 12)	0		0
Stockholders' equity:
Preferred stock; $.001 par value; 5,000,000 shares authorized and 0 shares issued and outstanding	0		0
Common stock; $.001 par value; 110,000,000 shares authorized; 81,052,359 issued and 81,002,359 outstanding for 2012 and 74,306,895 issued and 74,256,895 outstanding for 2011	81,052		74,307
Additional paid-in capital	79,471,324		73,868,604
Treasury stock (50,000 shares at cost)	(25,000)		(25,000)
Accumulated deficit	(63,859,067)		(62,021,346)
Total stockholders' equity	15,668,309		11,896,565
Total liabilities and stockholders' equity	$ 27,471,686		$ 27,096,192

[1] On January 5, 2011, the Company acquired Surgical Biologics, LLC. As a result, the Company recorded intangible assets for customer and supplier relationships, patents and know-how, licenses/permits, trade names and trademarks and in-process research and development.